*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Isavuconazole</strong> (CAS 171260-98-5) is a broad-spectrum triazole antifungal agent. Its core synthesis involves multi-step heterocyclic coupling to form the active triazolyl structure, characterized by the molecular formula C<sub>24</sub>H<sub>25</sub>N<sub>7</sub>O<sub>2</sub>S.</p>
<h3>Application</h3>
<ul>
<li>Invasive aspergillosis treatment in immunocompromised patients.</li>
<li>Mucormycosis therapy for adults requiring systemic antifungal intervention.</li>
<li>Manufacturing of pharmaceutical intermediates for oral capsule formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated with strong CYP3A4 inducers due to significant drug interactions. Store below 25°C in dry conditions away from light. Clinical use requires monitoring of QT interval prolongation risks.</p>